thalidomide
美 [θ??l?d??ma?d]
英 [θ??l?d?ma?d] 
- n.酞胺呱啶酮
- 網(wǎng)絡(luò)沙利度胺;沙利竇邁;反應(yīng)停
英漢雙解
1. | 酞胺呱啶酮,反應(yīng)停(一種鎮(zhèn)定藥,20 世紀(jì) 60 年代發(fā)現(xiàn)孕婦服用后會導(dǎo)致胎兒四肢畸形而被禁用)a sedative drug which was used until the 1960s, when it was discovered that if given to pregnant women, it prevented some babies from developing normal arms and legs |
英漢解釋
英英解釋
例句
Thalidomide is a drug with bad reputation from the 1960's as it appeared to be teratogenic by causing foetal anomalies.
沙利度胺是一種由1960年的壞名聲藥物的,因為它似乎是由導(dǎo)致胎兒畸形致畸。
Thalidomide, a new sleeping pill, is found to have caused birth defects in thousands of babies born in western Europe.
反應(yīng)停(Thalidomide),一種新的安眠藥,被發(fā)現(xiàn)已在西歐引起幾千名嬰兒的出生缺陷。
My left arm is a short stub with a small hand and three fingers, reminiscent of a thalidomide defect.
我的左手上面只有三根手指,并且手臂很短小,這讓我想起了“停缺損”。
The combination of thalidomide and dexamethasone is an effective induction therapy regimen for previously untreated multiple myeloma.
沙利度胺聯(lián)合地塞米松是初發(fā)骨髓瘤一個有效的治療方案。
We, therefore, attempted a trial of oral Thalidomide and achieved rapid biochemical and cytological remission with a short course.
因此,我們嘗試應(yīng)用口服沙利度胺治療,患者迅速獲得生化和細(xì)胞學(xué)緩解。
Patients who took other treatments, like thalidomide and interferon-alpha, had no higher risk, researchers said.
研究者指出,患者采用其他的治療藥物,比如薩利多胺或干擾素,所帶來的風(fēng)險要小一些。
Due to the failure of this treatment, treatment with thalidomide was started.
因為沒有這種待遇,沙利度胺治療開始。
The current progress in research on thalidomide was summarized, including its mechanism of anti-tumor, curative effect and pharmaceutics.
綜述近年來在沙利度胺的抗腫瘤作用機制、現(xiàn)有和潛在的臨床療效以及制劑學(xué)等方面的研究進(jìn)展。
To evaluate the efficacy of thalidomide and dexamethasone as induction therapy regimen in previously untreated multiple myeloma.
評估沙利度胺聯(lián)合地塞米松在初發(fā)骨髓瘤誘導(dǎo)治療中的療效。
To explore the effectivity and adverse reaction of thalidomide combined small-dose MP plan in treatment of senile multiple myeloma(MM).
探討沙利度胺聯(lián)合小劑量MP方案化療治療老年多發(fā)性骨髓瘤的臨床療效及不良反應(yīng)。
Objective To investigate the efficacy and toxicity on thalidomide in the treatment of refractory plasma cell neoplasms.
目的為觀察反應(yīng)停治療難治性漿細(xì)胞腫瘤的有效性和毒性。
Thalidomide and its analogues modulate the immune system in various ways.
酞胺哌啶酮及其類似物的調(diào)節(jié)免疫系統(tǒng)以不同的方式。
This is in part due to caution about giving newly developed drugs to pregnant women following the thalidomide crisis half a century ago.
這部分是由于半個世紀(jì)前發(fā)生沙利度胺(反應(yīng)停)事件以后對讓孕婦服用新開發(fā)藥物的謹(jǐn)慎。
OBJECTIVE: To evaluate research progress and the usage of thalidomide in hematologic disease.
目的:評價沙利度胺在血液病中的研究進(jìn)展及應(yīng)用概況。
abstract: Objective: To investigate the effects and mechanisms of thalidomide on human colorectal cancer cell HCT116.
目的:觀察沙利度胺對人結(jié)腸癌細(xì)胞HCT116增殖和遷移的影響,并初步探討其影響機制。
This article summarizes the application and mechanism of action of thalidomide in the treatment of some skin diseases.
介紹了沙利度胺在皮膚病治療中的應(yīng)用和作用機制等方面的進(jìn)展。
Thalidomide: The drug thalidomide is used to treat multiple myeloma, and has helped some patients with CD.
沙立度胺:沙力度胺用于治療多發(fā)性骨髓瘤,也幫助一些CD病人。
The famous example of thalidomide is a case for more animals testing, not less.
薩立多胺就是一個著名的例子,說明對動物進(jìn)行的實驗應(yīng)該更多而不是更少。
Thalidomide (1954): Drug formerly used as a sedative and to prevent morning sickness during pregnancy.
沙利竇邁(1954):過去曾用作鎮(zhèn)靜劑和妊娠時作為止吐劑使用的藥物。
Dr. Kelsey demanded better tests for thalidomide.
Kelsey要求對薩力多胺做更好的測試。
Take, for example, Thalidomide babies, Parkinson's sufferers, autism or people who have cerebral palsy.
以反應(yīng)停畸形兒、帕金森病患者、自閉癥或患大腦性麻痹的人為例。
Clinical observation of adverse reactions to thalidomide used for multiple myeloma
沙利度胺治療多發(fā)性骨髓瘤及其不良反應(yīng)的觀察
The clinical and experimental study of thalidomide in the treatment of ankylosing spondylitis
反應(yīng)停治療強直性脊柱炎的臨床與實驗研究
Clinical observation on thalidomide accompanied chemotherapy in treatment of patients with refractory or relapsed multiple myeloma
沙立度胺聯(lián)合化療治療難治性及復(fù)發(fā)性多發(fā)性骨髓瘤的臨床觀察
The clinical application and mechanisms evolution of thalidomide and its derivatives
沙利度胺及其衍生物臨床及作用機制研究進(jìn)展
The outcome and side-effects in patients with malignant plasma cell diseases treated with thalidomide combined with combination chemotherapy
沙利度胺加聯(lián)合化療治療惡性漿細(xì)胞疾病的療效和不良反應(yīng)
Combination of Arsenic Trioxide, Thalidomide and Dexamethasone in Treatment for Relapsed and Refractory Multiple Myeloma
三氧化二砷、沙利度胺和地塞米松聯(lián)合治療復(fù)發(fā)性、難治性多發(fā)性骨髓瘤
Clinical study of effects of thalidomide on cytokines in patients with multiple myeloma
沙立度胺對多發(fā)性骨髓瘤患者細(xì)胞因子影響的臨床研究
Application of Thalidomide to Hematologic Disease and Its Clinical Evaluation
沙利度胺在血液病中的應(yīng)用與臨床評價
Effect of chemotherapy of combined capecitabine with thalidomide on expression of thymidine phosphorylase in colorectal cancer tissue
卡培他濱聯(lián)合沙利度胺化療對結(jié)直腸癌組織胸苷磷酸化酶表達(dá)的影響
Interventional effects of thalidomide on levels of serum vascular endothelial growth factor in patients with myelofibrosis
原發(fā)性骨髓纖維化患者血管內(nèi)皮生長因子水平變化與反應(yīng)停的干預(yù)
Clinical observation of thalidomide in treating different types of cutaneous lesions of lupus erythematosus
沙利度胺治療不同類型紅斑狼瘡皮損的療效觀察
Preliminary study on the treatment of newly diagnosed multiple myeloma with thalidomide combined with chemotherapy
酞咪哌啶酮聯(lián)合化療初治多發(fā)性骨髓瘤療效觀察
Positive Immunoregulation of Thalidomide on Human Peripheral Blood Mononuclear Cell Cultures
沙利度胺對人外周血單個核細(xì)胞免疫正調(diào)控作用
Experimental study thalidomide for treatment of murine hepatocellular carcinoma
沙利度胺治療肝癌的實驗研究
The Clinical Research of Thalidomide Incorporation With Dexamethasone in Treatment of Multiple Myeloma
沙利度胺與地塞米松聯(lián)合治療多發(fā)性骨髓瘤的臨床研究
Clinical study on thalidomide alone or combined with dexamethasone in the treatment of refractory and relapsed multiple myeloma
沙利度胺聯(lián)合地塞米松治療難治性復(fù)發(fā)性多發(fā)性骨髓瘤的臨床療效
Clinical study on thalidomide alone or combined with dexamethasone in the treatment of relapsed and refractory multiple myeloma
沙利度胺治療難治性復(fù)發(fā)性多發(fā)性骨髓瘤的臨床研究
Influence of Thalidomide on Bone Marrow Microenvironment in Refractory and Relapsed Multiple Myeloma
沙利度胺對難治、復(fù)發(fā)多發(fā)性骨髓瘤患者骨髓微環(huán)境的影響
The efficacy of thalidomide in combination with chemotherapy in refractory recurrent non-Hodgkin lymphoma
肽咪胍啶酮聯(lián)合化療治療難治復(fù)發(fā)性非霍奇金淋巴瘤